• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲肥厚型心肌病患者左心房应变参数与传统左心房参数对不良结局预测的预后意义——一项超声心动图研究

The Prognostic Implication of Left Atrial Strain Parameters with Conventional Left Atrial Parameters for the Prediction of Adverse Outcomes in Asian Patients with Hypertrophic Cardiomyopathy-An Echocardiographic Study.

作者信息

Seah Andre, Li Tony Y W, Sari Novi Yanti, Lee Chi-Hang, Yeo Tiong-Cheng, Yip James W L, Lim Yoke Ching, Poh Kian-Keong, Kong William K F, Lin Weiqin, Sia Ching-Hui, Wong Raymond C C

机构信息

Department of Medicine, National University Health System, Singapore 119074, Singapore.

Department of Cardiology, National University Heart Centre, Singapore 119228, Singapore.

出版信息

J Cardiovasc Dev Dis. 2025 Jul 8;12(7):261. doi: 10.3390/jcdd12070261.

DOI:10.3390/jcdd12070261
PMID:40710786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12296001/
Abstract

BACKGROUND/OBJECTIVES: Left atrial function can be a tool for risk stratification for hypertrophic cardiomyopathy (HCM). Over the past decade, there has been growing interest in the application of strain analysis for earlier and more accurate prediction of cardiovascular disease prognosis. This study aimed to investigate the performance of left atrial strain analysis compared to conventional left atrial measures in predicting clinical outcomes in Asian patients with HCM.

METHODS AND RESULTS

This was a retrospective study involving 291 patients diagnosed with HCM between 2010 and 2017. Left atrial volumes were assessed using the method of discs in orthogonal plans at both end diastole and end systole. Left atrial (LA) strain was obtained using a post-hoc analysis with TOMTEC software. We tested the various left atrial parameters against outcomes of (1) heart failure hospitalization and (2) event-free survival from a composite of adverse events, including all-cause mortality, ventricular tachycardia (VT)/ventricular fibrillation (VF) events, appropriate device therapy if an implantable cardioverter defibrillator (ICD) was implanted, stroke, and heart failure hospitalization. The patients had a mean age of 59.0 ± 16.7 years with a male preponderance (71.2%). The cumulative event-free survival over a follow-up of 3.9 ± 2.7 years was 55.2% for patients with an abnormal LA strain versus 82.4% for patients without one ( < 0.001). Multivariable Cox regression analyses were performed separately for each LA parameter, adjusting for age, sex, LV mass index, LV ejection fraction (EF), E/e', the presence of LV outflow tract (LVOT) obstruction at rest, and atrial fibrillation. An analysis showed that all parameters except for LAEF demonstrated an independent association with heart failure hospitalization. Left atrial strain outperformed the rest of the parameters by demonstrating an association with a composite of adverse events.

CONCLUSIONS

In Asian patients with HCM, measures of left atrial strain were independently associated with heart failure hospitalization and a composite of adverse outcomes. Left atrial strain may be used as a tool to predict adverse outcomes in patients with HCM.

摘要

背景/目的:左心房功能可作为肥厚型心肌病(HCM)危险分层的一项指标。在过去十年中,人们越来越关注应变分析在更早、更准确预测心血管疾病预后方面的应用。本研究旨在探讨与传统左心房测量指标相比,左心房应变分析在预测亚洲HCM患者临床结局方面的性能。

方法与结果

这是一项回顾性研究,纳入了2010年至2017年间确诊为HCM的291例患者。采用正交平面圆盘法在舒张末期和收缩末期评估左心房容积。使用TOMTEC软件进行事后分析获得左心房(LA)应变。我们针对以下结局测试了各种左心房参数:(1)心力衰竭住院;(2)包括全因死亡率、室性心动过速(VT)/心室颤动(VF)事件、植入植入式心律转复除颤器(ICD)时的适当器械治疗、中风和心力衰竭住院在内的不良事件综合结果的无事件生存期。患者的平均年龄为59.0±16.7岁,男性占优势(71.2%)。在3.9±2.7年的随访中,LA应变异常患者的累积无事件生存率为55.2%,而无LA应变异常患者为82.4%(P<0.001)。对每个LA参数分别进行多变量Cox回归分析,并对年龄、性别、左心室质量指数、左心室射血分数(EF)、E/e'、静息时左心室流出道(LVOT)梗阻的存在情况和心房颤动进行校正。分析表明,除LAEF外,所有参数均与心力衰竭住院存在独立关联。左心房应变通过显示与不良事件综合结果的关联,优于其他参数。

结论

在亚洲HCM患者中,左心房应变测量与心力衰竭住院及不良结局综合结果独立相关。左心房应变可作为预测HCM患者不良结局的一项指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/45032001dfb7/jcdd-12-00261-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/ee5b7ed43681/jcdd-12-00261-g0A1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/b6615ca346c3/jcdd-12-00261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/00d33dc3be7b/jcdd-12-00261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/45032001dfb7/jcdd-12-00261-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/ee5b7ed43681/jcdd-12-00261-g0A1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/b6615ca346c3/jcdd-12-00261-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/00d33dc3be7b/jcdd-12-00261-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3068/12296001/45032001dfb7/jcdd-12-00261-g003.jpg

相似文献

1
The Prognostic Implication of Left Atrial Strain Parameters with Conventional Left Atrial Parameters for the Prediction of Adverse Outcomes in Asian Patients with Hypertrophic Cardiomyopathy-An Echocardiographic Study.亚洲肥厚型心肌病患者左心房应变参数与传统左心房参数对不良结局预测的预后意义——一项超声心动图研究
J Cardiovasc Dev Dis. 2025 Jul 8;12(7):261. doi: 10.3390/jcdd12070261.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层:一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.
4
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
5
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

本文引用的文献

1
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Design, Rationale, and Baseline Characteristics of ODYSSEY-HCM.玛伐卡坦治疗有症状的非梗阻性肥厚型心肌病:ODYSSEY-HCM研究的设计、原理及基线特征
JACC Heart Fail. 2025 Feb;13(2):358-370. doi: 10.1016/j.jchf.2024.11.013.
2
Unveiling the reliability of left atrial strain measurement: a dedicated speckle tracking software perspective in controls and cases.揭示左心房应变测量的可靠性:从专用斑点追踪软件角度看对照组和病例组情况
Eur Heart J Imaging Methods Pract. 2024 Jun 24;2(1):qyae061. doi: 10.1093/ehjimp/qyae061. eCollection 2024 Jan.
3
Effects of sex on clinical outcomes of hypertrophic cardiomyopathy in Singapore.
新加坡肥厚型心肌病患者的临床结局与性别的影响。
Ann Acad Med Singap. 2023 Jul 28;52(7):348-355. doi: 10.47102/annals-acadmedsg.2022344.
4
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.2024 年美国心脏协会/美国心脏病学会/美国运动医学会/心律学会/起搏与电生理学会/心血管磁共振学会肥厚型心肌病管理指南:美国心脏协会/美国心脏病学会临床实践指南联合委员会的报告。
J Am Coll Cardiol. 2024 Jun 11;83(23):2324-2405. doi: 10.1016/j.jacc.2024.02.014. Epub 2024 May 8.
5
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy.从心房颤动管理到心房心肌病评估:肥厚型心肌病中左心房疾病的概念演变。
Can J Cardiol. 2024 May;40(5):876-886. doi: 10.1016/j.cjca.2024.01.026. Epub 2024 Jan 28.
6
Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.肥厚型心肌病伴射血分数保留心力衰竭患者的临床特征和预后。
Clin Res Cardiol. 2024 May;113(5):761-769. doi: 10.1007/s00392-023-02371-5. Epub 2024 Jan 10.
7
Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management.心尖肥厚型心肌病:病理生理学、诊断与治疗。
Clin Res Cardiol. 2024 May;113(5):680-693. doi: 10.1007/s00392-023-02328-8. Epub 2023 Nov 20.
8
Echocardiographic Reference Ranges of Global Longitudinal Strain for All Cardiac Chambers Using Guideline-Directed Dedicated Views.使用指南指导的专用视图获得所有心腔的整体纵向应变超声心动图参考范围。
JACC Cardiovasc Imaging. 2023 Dec;16(12):1516-1531. doi: 10.1016/j.jcmg.2023.08.011. Epub 2023 Nov 1.
9
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial.肥厚型心肌病患者行间隔心肌切除术的治疗:VALOR-HCM 随机临床试验第 56 周的结果。
JAMA Cardiol. 2023 Oct 1;8(10):968-977. doi: 10.1001/jamacardio.2023.3342.
10
Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study.左房应变分析对肥厚型心肌病患者不良临床事件的预测价值:一项 CM R 研究。
BMC Cardiovasc Disord. 2023 Jan 23;23(1):42. doi: 10.1186/s12872-023-03069-2.